Telomir Pharmaceuticals Q4 2025 Earnings WiderthanExpected Loss as Revenue Remains Absent Bitcoin Edges Higher Amid Elevated Bond Yields and Geopolitical Optimism on USIran Relations Woodward WWD Q1 2026 Earnings Strong EPS Beat Bolstered by Operational Gains Yet Shares Edge Lower MTCH Q1 2026 Earnings EPS Beats Estimates by 889 as Stock Edges Lower Indian Equities Remain Under Foreign Selling Pressure Amid Outperformance of US Markets RBC Capital Flags Potential Q1 Upside for Snowflake Amid Strong Cortex Code Adoption and Steady Product Revenue Growth Oil Prices Rise as Trump Issues Fresh Warning to Iran European Markets Dip